Phase IV / Post-Marketing CROs in Europe
23 published
23 published CROs match Phase IV / Post-Marketing in Europe.
Locations in this set include United States, United Kingdom, India, China, Germany, and Australia.
Capabilities that show up most often in this set: Biologics (Other), Small Molecule, Vaccine, Biologics (Monoclonal Antibodies), and Gene Therapy.
Matching companies
Velocity Clinical ResearchIntegrated clinical research site organization operating 60+ sites across the U.S. and Europe, supporting trials that contributed to 61 FDA-approved products since 1986.
VeranexVeranex is an Innovation CRO uniting design, preclinical, clinical, regulatory, and market-access expertise for medical devices and diagnostics. The company accelerates development from concept through commercialization with integrated cross-disciplinary teams across 15 international hubs.
WuXi AppTecGlobal CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.
Markdown mirror: /services/phase-4-post-marketing/europe.md